Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study
By
- AMS
posted
Aug 11, 2021 10:49 AM
0
Recommend
.
0 comments
0 views
Related Content
Elderly patients with psoriasis: long-term efficacy and safety of modern treatments
- AMS
Added Aug 20, 2020
Blog Entry
FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants
- AMS
Added Nov 10, 2021
Blog Entry
Deferred time of delivery of biologic therapies in patients with stabilized psoriasis leads to a ‘perceived satisfaction’: a multicentric study
- AMS
Added Apr 29, 2020
Blog Entry
Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials
- AMS
Added Oct 21, 2020
Blog Entry
A subset analysis of efficacy and safety outcomes from phase 3 clinical studies of ixekizumab for the treatment of patients with severe plaque psoriasis
- AMS
Added Apr 21, 2020
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic